Skip to main content
Office of Research and Innovation
NC State Office of Research Commercialization

Unlocking Innovation

Incredible technologies are coming out of NC State. Discover how they’re creating positive economical, technological and societal impact.

Innovation, Collaboration and Support

The Office of Research Commercialization (ORC) cultivates an environment of scientific and entrepreneurial excellence and bridges connections from NC State University’s research community to industry and startups by strategically evaluating, protecting and licensing technology.

NC State to Partner With ChromaGenix on Transformative Toolkit for Manufacturing Biological Therapies

ChromaGenix’s portfolio of technologies for purifying biological therapeutics originated in the College of Engineering and was initially commercialized by the NC State spinout company LigaTrap Technologies. The new research partnership will focus on discovering and developing the next generation of affinity ligands for the purification of vital medicines.

Full Article
The Wolfpack community enjoyed a laser show at the Belltower during Packapalooza festivities on August 26, 2023. Photo by Becky Kirkland

News Feed

More

May 06, 2025

Student Entrepreneurs Leverage I-Corps to Turn Software Project into Successful Exit

QuikCal, a startup founded by undergraduate engineering students at Duke University, was recently acquired by MOCA Systems, Inc., a leading provider of construction planning software, for its artificial intelligence-driven tool…

May 01, 2025

NC State to Partner With ChromaGenix on Transformative Toolkit for Manufacturing Biological Therapies

NC State University will partner with ChromaGenix, a life science company that wants to transform the field of affinity purification technologies, on research to expand the company’s ligand discovery platform.…

April 16, 2025

NC State Science to Supplement: CodonRX Pioneers a New Era in Gut Health

Innovation at NC State University is transforming lives, one scientific breakthrough at a time. The latest success story, CodonRX, a probiotic supplement designed to reduce gastrointestinal inflammation, is already making an impact on digestive health worldwide.